Unbiased AI-powered news
A newly identified pathway dampens inflammasome activation in osteoclasts to regulate bone resorption. This discovery addresses a paradox in bone biology by revealing a key restraint mechanism. The findings were reported in a scientific publication.
Substrate placeholder — needs reviewResearchers have identified a pathway that regulates bone resorption by reducing the activation of inflammasomes in osteoclasts, according to a report from SciSignal. This mechanism acts as a restraint on bone breakdown processes. The discovery helps resolve a paradox in the field of bone biology, where previous models did not fully explain controls on resorption.
resorption involves osteoclasts breaking down bone tissue, a process balanced with bone formation to maintain skeletal health. Inflammasomes are protein complexes that trigger inflammatory responses, and their activation in osteoclasts can influence resorption rates. The identified pathway dampens this activation, providing a regulatory check.
This finding highlights a specific biological restraint that could inform future studies on bone-related conditions. Researchers noted that it addresses inconsistencies in existing bone biology models.
The Ministry of Health reported 1,003 cases and 254 deaths as of the latest count, with 100 recoveries. The Bundibugyo virus outbreak, declared May 15 in Ituri province, has spread to neighboring provinces and Uganda.
entrepreneur.comAbbVie will pay $10.9 billion in cash to buy Apogee Therapeutics, a Waltham-based developer of immunology drugs. The deal values Apogee shares at $135.11 each, a roughly 50 percent premium to the prior close.
The IndependentRecord spring rains and snowmelt flooded northern Michigan homes, exposing gaps in federal flood maps and insurance access for thousands of residents. Many property owners had been told they were outside mapped flood zones and could not obtain coverage.